1 |
Bhandari S, Jha P, Thakur A, et al. Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment [J]. Clin Auton Res, 2018, 28(2): 203-209.
|
2 |
Yang HR. Recent concepts on cyclic vomiting syndrome in children [J]. J Neurogastroenterol Motil, 2010, 16(2): 139-147.
|
3 |
Saps M, Velasco-Benitez CA, Langshaw AH, et al. Prevalence of functional gastrointestinal disorders in children and adolescents: comparison between Rome III and Rome IV criteria [J]. J Pediatr, 2018, 199: 212-216.
|
4 |
Robin SG, Keller C, Zwiener R, et al. Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV criteria [J]. J Pediatr, 2018, 195: 134-139.
|
5 |
Romano C, Dipasquale V, Rybak A, et al. An overview of the clinical management of cyclic vomiting syndrome in childhood [J]. Curr Med Res Opin, 2018, 34(10): 1785-1791.
|
6 |
Li BU, Lefevre F, Chelimsky GG, et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome [J]. J Pediatr Gastroenterol Nutr, 2008, 47(3): 379-393.
|
7 |
Lin YP, Ni YH, Weng WC, et al. Cyclic vomiting syndrome and migraine in children [J]. J Formos Med Assoc, 2011, 110(6): 382-387.
|
8 |
Ellingsen DM, Garcia RG, Lee J, et al. Cyclic vomiting syndrome is characterized by altered functional brain connectivity of the insular cortex: a cross-comparison with migraine and healthy adults [J]. Neurogastroenterol Motil, 2017, 29(6).
|
9 |
Wang Q, Ito M, Adams K, et al. Mitochondrial DNA control region sequence variation in migraine headache and cyclic vomiting syndrome [J]. Am J Med Genet A, 2004, 131(1): 50-58.
|
10 |
Boles RG, Adams K, Li BU. Maternal inheritance in cyclic vomiting syndrome [J]. Am J Med Genet A, 2005, 133A(1): 71-77.
|
11 |
Salpietro CD, Briuglia S, Merlino MV, et al. A mitochondrial DNA mutation (A3243G mtDNA) in a family with cyclic vomiting [J]. Eur J Pediatr, 2003, 162(10): 727-728.
|
12 |
Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome [J]. Cephalalgia, 2009, 29(7): 719-728.
|
13 |
Redon S, Mareau C, Guedj E, et al. Cyclic vomiting syndrome in adults and children: a hypothesis [J]. Headache, 2017, 57(6): 943-951.
|
14 |
Donnet A, Redon S. Cyclic vomiting syndrome in children [J]. Curr Pain Headache Rep, 2018, 22(4): 30.
|
15 |
Venkatesan T, Sengupta J, Lodhi A, et al. An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS) [J]. Exp Brain Res, 2014, 232(8): 2563-2570.
|
16 |
Evans RW, Whyte C. Cyclic vomiting syndrome and abdominal migraine in adults and children [J]. Headache, 2013, 53(6): 984-993.
|
17 |
Benninga MA, Faure C, Hyman PE, et al. Childhood functional gastrointestinal disorders: neonate/toddler [J]. Gastroenterology, 2016, pii: S0016-5085(16)00182-7.
|
18 |
Hyams JS, Di Lorenzo C, Saps M, et al. Functional disorders: children and adolescents [J]. Gastroenterology, 2016, pii: S0016-5085(16)00181-5.
|
19 |
Headache Classification Committee of the International Headache Society (IHS).The international classification of headache disorders, 3rd edition [J]. Cephalalgia, 2018, 38(1): 1-211.
|
20 |
Hikita T, Kodama H, Kaneko S, et al. Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial [J]. Cephalalgia, 2011, 31(4): 504-507.
|
21 |
Kumar N, Bashar Q, Reddy N, et al. Cyclic vomiting syndrome (CVS): is there a difference based on onset of symptoms-pediatric versus adult? [J]. BMC Gastroenterol, 2012, 12: 52.
|
22 |
Cristofori F, Thapar N, Saliakellis E, et al. Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome [J]. Aliment Pharmacol Ther, 2014, 40(3): 309-317.
|
23 |
Hejazi RA, Reddymasu SC, Namin F, et al. Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two-year follow-up study [J]. J Clin Gastroenterol, 2010, 44(1): 18-21.
|
24 |
Sezer OB, Sezer T. A new approach to the prophylaxis of cyclic vomiting: topiramate [J]. J Neurogastroenterol Motil, 2016, 22(4): 656-660.
|
25 |
Badihian N, Saneian H, Badihian S, et al. Prophylactic therapy of cyclic vomiting syndrome in children: comparison of amitriptyline and cyproheptadine: a randomized clinical trial [J]. Am J Gastroenterol, 2018, 113(1): 135-140.
|
26 |
Boles RG. High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series [J]. BMC Neurol, 2011, 11: 102.
|
27 |
Boles RG, Lovett-Barr MR, Preston A, et al. Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study [J]. BMC Neurol, 2010, 10: 10.
|
28 |
Martinez-Esteve Melnikova A, Schäppi MG, Korff C. Riboflavin in cyclic vomiting syndrome: efficacy in three children [J]. Eur J Pediatr, 2016, 175(1): 131-135.
|
29 |
Vidula MK, Wadhwani A, Roberts K, et al. Use of a once-daily NSAID in treatment of cyclic vomiting syndrome [J]. J Gen Intern Med, 2014, 29(3): 543-546.
|
30 |
Hayes WJ, Weisensee LA, Kappes JA, et al. OnabotulinumtoxinA injections for the treatment of cyclic vomiting syndrome [J]. Pharmacotherapy, 2015, 35(5): e51-e55.
|
31 |
Fitzpatrick E, Bourke B, Drumm B, et al. The incidence of cyclic vomiting syndrome in children: population-based study [J]. Am J Gastroenterol, 2008, 103(4): 991-995; quiz 996.
|
32 |
Hikita T, Kodama H, Ogita K, et al. Cyclic vomiting syndrome in infants and children: a clinical follow-up study [J]. Pediatr Neurol, 2016, 57: 29-33.
|